NeoGenomics (MEX:NEO) Construction In Progress: MXN0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NEO NeoGenomics Inc MEX:NEO
74 GF Score
Price MXN176.40
GF Value MXN177.40
! 6 Warning Signs
View Full Analysis

What is NeoGenomics Construction In Progress?

NeoGenomics MEX:NEO 74 Construction In Progress is MXN0 Mil as of Jun. 2026. GuruFocus rates MEX:NEO with a GF Score™ of 74/100 and a GF Value™ of MXN177.40. The stock has 6 warning signs investors should review.

NeoGenomics's quarterly construction in progress declined from Dec. 2025 (MXN139 Mil) to Mar. 2026 (MXN0 Mil) but then stayed the same from Mar. 2026 (MXN0 Mil) to Jun. 2026 (MXN0 Mil).

NeoGenomics's annual construction in progress increased from Dec. 2023 (MXN61 Mil) to Dec. 2024 (MXN178 Mil) but then declined from Dec. 2024 (MXN178 Mil) to Dec. 2025 (MXN139 Mil).

NeoGenomics Construction In Progress Historical Data

* Premium members only.

The historical data trend for NeoGenomics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoGenomics Construction In Progress Chart

NeoGenomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 254.27 175.15 61.31 177.50 139.13

NeoGenomics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 139.13 0.00 0.00
MEX:NEO
74GF Score
NeoGenomics Inc MEX:NEO
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeoGenomics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of MXN0 Mil mean?
NeoGenomics (MEX:NEO) has a Construction In Progress of MXN0 Mil as of Jun. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on NeoGenomics and its competitors.
Is NeoGenomics' Construction In Progress too high?
NeoGenomics' current Construction In Progress is MXN0 Mil. Overall, NeoGenomics has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does NeoGenomics' Construction In Progress compare to WGS and CDNA?
NeoGenomics' Construction In Progress of MXN0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Diagnostics & Research company?
A good Construction In Progress depends on the Medical Diagnostics & Research industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on NeoGenomics and its competitors. NeoGenomics's current Construction In Progress is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeoGenomics stock overvalued right now?
NeoGenomics (MEX:NEO) has a current Construction In Progress of MXN0 Mil. The stock's GF Value™ is MXN177.40, compared to a current price of MXN176.40 — trading 0.6% below its estimated fair value. The current Construction In Progress is MXN0 Mil. NeoGenomics' overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For NeoGenomics (MEX:NEO), the current Construction In Progress is MXN0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeoGenomics (MEX:NEO) Overvalued in 2026?

Based on GuruFocus' analysis, NeoGenomics stock appears to be undervalued. The current stock price of MXN176.40 is trading 0.6% below its estimated GF Value™ of MXN177.40.

Key valuation signals for MEX:NEO:

  • Construction In Progress: MXN0 Mil
  • GF Value™: MXN177.40 vs. price of MXN176.40 (0.6% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the MEX:NEO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeoGenomics Business Description

Other Exchanges NEO:USANG9:Germany
Address 9490 NeoGenomics Way, Fort Myers, FL, USA, 33912
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
74GF Score

Get the complete analysis for MEX:NEO

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN176.40
Price
MXN177.40
GF Value